Rising Demand for Non-Invasive Technique for Early Detection of Cancer is Driving the Europe Medical Terahertz Technology Market
THz pulse imaging, THz time-domain spectroscopy (TDS-THz), continuous-wave terahertz (CW-THz), and other non-invasive terahertz generation/detection approaches are among the most promising for detecting cancer. Terahertz imaging produces a stronger contrast image of the diseased tissue because diseased tissue has a higher water content than healthy tissue, which may allow for a more precise definition of early-stage malignancies' exact margin (border). In real-time, terahertz imaging can help a doctor avoid removing healthy tissue around a tumor as a safety margin during breast cancer surgery. They can ensure that all sick tissue is removed, avoiding the need for multiple operations and lowering the patient's risk. THz technologies also demonstrated their potential uses in the biomedical sciences, including both potential innovative diagnostic procedures for skin tumors and potential novel treatments for skin malignancies and other skin conditions. Overall, the burden of cancer incidence and death is increasing, reflecting population aging, is the key cancer risk factors, are the factors driving the market growth
Europe Medical Terahertz Technology Market Overview
Terahertz (THz) is nonionizing radiation that makes it safe for living tissues. It can be used safely to pick up several types of explosives, compounds used in pharmaceutical ingredients, and illegal narcotics. Cardiovascular disease is the major cause of death in the European Union. According to Eurostat, in 2019, Germany conducted 45,400 heart bypass surgery. As per Cancer Atlas, in 2018, 3.9 million new cancer cases and 1.9 million cancer-related deaths were reported in Europe. Furthermore, breast cancer is the leading type of cancer, which contributes to 523,000 new cases, or 13% of all cancer cases. Terahertz technology is applied in the field of biology and medicine, such as medical imaging, cancer diagnosis, and material spectroscopy. Thus, the growing number of diseases are expected to boost the medical terahertz technology market growth. In 2019, an EU-funded initiative, the THEIA project using THz technology, has laid the foundation for application in biology, medicine, material science, and security using the unique properties of THz waves. It will be used to develop novel scanners and imaging systems. The THz spectrum possesses unique fingerprints for compounds such as polymers, proteins, amino acids, drugs, and explosives. Therefore, this technology can be used in security scanners. It will help recognize drugs, explosives, and other illicit substances. Thus, growing research in medical THz technology will fuel the growth of the Europe medical terahertz technology market.
Europe Medical Terahertz Technology Market Segmentation
The Europe medical terahertz technology market is segmented into type, application, and country.
Based on type, the Europe medical terahertz technology market is segmented into terahertz imaging and terahertz spectroscopy. The terahertz imaging segment held the largest share of the Europe medical terahertz technology market in 2022.
Based on application, the Europe medical terahertz technology market is segmented into oncology, dentistry, dermatology, tomography, biochemistry, and others. In 2022, the oncology segment is likely to hold the largest share of the Europe medical terahertz technology market.
Based on country, the Europe medical terahertz technology market is segmented into France, Germany, Italy, Spain, the UK, Russia, and the Rest of Europe. Germany dominated the market share in 2022.
Acal BFi Limited; Advantest Corporation; HÜBNER GmbH & Co. KG; Luna Innovations Inc.; Menlo Systems GmbH; Microtech Instrument Inc.; Terasense Group Inc.; Teraview limited; and Toptica Photonics AG are the leading companies operating in the Europe medical terahertz technology market.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 39.90 Million |
| Market Size by 2028 | US$ 101.84 Million |
| CAGR (2022 - 2028) | 16.9% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2028 |
| Segments Covered |
By Type
|
|
Regions and Countries Covered
|
|
| Europe | UK, Germany, France, Russia, Italy, Rest of Europe |
| Market leaders and key company profiles |
|
The Europe Medical Terahertz Technology Market is valued at US$ 39.90 Million in 2022, it is projected to reach US$ 101.84 Million by 2028.
As per our report Europe Medical Terahertz Technology Market, the market size is valued at US$ 39.90 Million in 2022, projecting it to reach US$ 101.84 Million by 2028. This translates to a CAGR of approximately 16.9% during the forecast period.
The Europe Medical Terahertz Technology Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Medical Terahertz Technology Market report:
The Europe Medical Terahertz Technology Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Medical Terahertz Technology Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Medical Terahertz Technology Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+1 646 791 7070
sales@businessmarketinsights.com
Get Free Sample For Europe Medical Terahertz Technology Market
